Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions reflect a balanced interest and recognition of the study's importance, with posts mentioning key findings like kratom's effect on liver enzymes and its role in managing opioid withdrawal, using words like 'potential drug interactions' and 'critical knowledge gaps.' The tone suggests a cautious but attentive attitude toward the implications of this research.
Most discussions recognize the significance of the study, with some explicitly agreeing on its importance by highlighting its findings and implications.
The posts demonstrate moderate interest, as they share the study's details without overly emotional language but show curiosity about the research developments.
The engagement is moderate; some posts reference specific aspects like the chemical mechanisms and clinical relevance, indicating a thoughtful level of participation.
The overall perception is that this research is potentially impactful, especially given the emphasis on drug interactions and safety concerns associated with kratom.
Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on the rise for managing opioid withdrawal & pain. These data fill critical knowledge gaps about the safe use kratom. @ASCPT_ClinPharm https://t.co/bCfstFVsip
Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on the rise for managing opioid withdrawal & pain. These data fill critical knowledge gaps about the safe use kratom. @ASCPT_ClinPharm https://t.co/bCfstFW07X
Congrats to Rakshit Tanna from Paine lab selected as a recipient of the prestigious @ASCPT_ClinPharm 2023 Presidential Trainee Award for his abstract, “Clinical assessment of the drug interaction potential of the psychotropic natural product kratom (Mitragyna speciosa).” https://t.co/P7rlkIwWPx
And there's a new human clinical study (Tanna et al 2023) showing kratom is a CYP3A inhibitor as previous in vitro studies have shown. This means "Co-consuming kratom with certain drugs extensively metabolized by CYP3A may precipitate serious interactions" https://t.co/gpOVHKKawE
Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on the rise for managing opioid withdrawal & pain. These data fill critical knowledge gaps about the safe use kratom. @ASCPT_ClinPharm https://t.co/bCfstFVsip
Showcasing Rakshit Tanna from Paine lab who was selected as recipients of the prestigious @ASCPT_ClinPharm 2023 Presidential Trainee Award for his abstract, “Clinical assessment of the drug interaction potential of the psychotropic natural product kratom (Mitragyna speciosa).” https://t.co/SLCU0hCgtA
Kratom can affect certain forms of CYP enzymes that are crucial in the metabolization of pharmaceutical drugs. This may lead to adverse reactions such as serotonin syndrome, organ toxicity, or even death, especially…
Responding to recent podcast feedback, this video explores Kratom's neuropharmacology, mechanisms of action, and drug interaction potential, emphasizing its effects on the human body based on recent scientific reviews…
Jacob interviews Wendy from Kratom Danger Awareness about her son Joseph's death from kratom toxicity, with no other substances involved. Scientific studies on kratom's health risks and drug interactions are discussed.
Kratom can interact with other meds! A new study shows it can increase the effects of some drugs metabolized by the liver, leading to dangerous side effects. https://t.co/WlcmzFwCrU #kratom #druginteractions #health #wellbeing #naturalproducts #NPDIs
Showcasing Rakshit Tanna from Paine lab who was selected as recipients of the prestigious @ASCPT_ClinPharm 2023 Presidential Trainee Award for his abstract, “Clinical assessment of the drug interaction potential of the psychotropic natural product kratom (Mitragyna speciosa).” https://t.co/SLCU0hCgtA
RT @NaPDICenter: Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on…
Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on the rise for managing opioid withdrawal & pain. These data fill critical knowledge gaps about the safe use kratom. @ASCPT_ClinPharm https://t.co/bCfstFW07X
Congrats to Rakshit Tanna from Paine lab selected as a recipient of the prestigious @ASCPT_ClinPharm 2023 Presidential Trainee Award for his abstract, “Clinical assessment of the drug interaction potential of the psychotropic natural product kratom (Mitragyna speciosa).” https://t.co/P7rlkIwWPx
We are excited to share our paper “Clinical assessment of the drug interaction potential of the psychotropic natural product kratom” by Tanna, Nguyen, et al, accepted to #CPTJournal. See it here: https://t.co/WlcmzFwCrU #ASCPTJournalFamily @ASCPT_ClinPharm @ASCPTjournals
RT @NaPDICenter: Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on…
RT @NaPDICenter: Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on…
Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on the rise for managing opioid withdrawal & pain. These data fill critical knowledge gaps about the safe use kratom. @ASCPT_ClinPharm https://t.co/bCfstFVsip
@SherryJOwings https://t.co/ZzcISRdyvO
RT @NaPDICenter: Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on…
RT @NaPDICenter: Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on…
Study by @nadjacech @OberliesGroup et al reveals potential drug interactions with #kratom. Oral kratom formulations are on the rise for managing opioid withdrawal & pain. These data fill critical knowledge gaps about the safe use kratom. @ASCPT_ClinPharm https://t.co/bCfstFVsip
RT @NaPDICenter: Exciting new study out on the drug interaction potential of the psychotropic natural product kratom. Check out the article…
Exciting new study out on the drug interaction potential of the psychotropic natural product kratom. Check out the article by Tanna RS et al. in @ASCPTjournals Clinical Pharmacology & Therapeutics. #Kratom #DrugInteractions #ClinicalResearch https://t.co/WlcmzFwCrU
RT @NaPDICenter: We are excited to share our paper “Clinical assessment of the drug interaction potential of the psychotropic natural produ…
We are excited to share our paper “Clinical assessment of the drug interaction potential of the psychotropic natural product kratom”, accepted to #CPTJournal. See it here: https://t.co/WlcmzFwCrU #ASCPTJournalFamily @ASCPTJournals
RT @kratomscience: And there's a new human clinical study (Tanna et al 2023) showing kratom is a CYP3A inhibitor as previous in vitro studi…
And there's a new human clinical study (Tanna et al 2023) showing kratom is a CYP3A inhibitor as previous in vitro studies have shown. This means "Co-consuming kratom with certain drugs extensively metabolized by CYP3A may precipitate serious interactions" https://t.co/gpOVHKKawE